Dhaka,   Thursday 19 November 2026

Drug administration approves Oxford University vaccine

Published: 00:00, 5 January 2021

Drug administration approves Oxford University vaccine

SAT DESK : Directorate General of Drug Administration (DGDA) of Bangladesh on Monday approved the Oxford University-AstraZeneca coronavirus vaccine for emergency use, paving the way for importing the vaccine from Serum Institute of India.

The drug administration gave Beximco Pharmaceuticals Ltd, the local partner of Serum, the no objection certificate (NOC) required to import the shots branded Covishield.

Major General Mahbubur Rahman, director general of DGDA, said the DGDA gave the NOC to import the vaccine and approved its emergency use because registering it would be a time-consuming process.

Beximco Pharmaceuticals Ltd has collected the NOC from the DGDA, and using it, they can now begin the procedure to bring the vaccine from India, he further added.

Earlier on Monday, amid the confusion that India had barred export of Covid-19 vaccines until its local needs were met, Health Minister Zahid Maleque and Foreign Minister Dr AK Abdul Momen both said there was no need to worry.

Saying that Bangladesh would get the delivery of its vaccine shipment from India on time, the foreign minister said: "Decision has been taken at the highest level, and that will be implemented. Nobody has to worry or get panicked," he told reporters, sharing the updates Ministry of Foreign Affairs had received from the Indian Ministry of External Affairs.

Advertisement